​

Funding Round

Venture Round - ImaginAb

Venture Round - ImaginAb

Investment Firm

Overview

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

Announced Date

Jun 03, 2021

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Adage Capital Management

Adage Capital Management

Adage Capital Management is a early_stage_venture and late_stage_venture and post_ipo firm.

Participant Investors

5

Investor Name
Participant InvestorNorgine Ventures
Participant InvestorAdage Capital Management
Participant InvestorCycad Group
Participant InvestorJames Pallotta
Participant InvestorTheravance Biopharma

Round Details and Background

ImaginAb raised $12800000 on 2021-06-03 in Venture Round

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 14, 2017
Venture Round - ImaginAb
5-8.0M
Apr 12, 2016
Venture Round - ImaginAb
-5.3M
May 08, 2014
Series B - ImaginAb
4-21.0M
Mar 27, 2012
Series A - ImaginAb
3-12.5M

Recent Activity

There is no recent news or activity for this profile.